Invus

Summary

In 1985 was created Invus, which is appeared as VC. The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Invus, startups are often financed by Polaris Partners, Versant Ventures, The Column Group. The meaningful sponsors for the fund in investment in the same round are Fidelity Management and Research Company, Polaris Partners, Redmile Group. In the next rounds fund is usually obtained by InterWest Partners, Wipro Technologies, Wing Venture Capital.

Among the most popular fund investment industries, there are Biotechnology, Software. Among the various public portfolio startups of the fund, we may underline Moderna Therapeutics, Kythera Biopharmaceuticals, Gossamer Bio For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

The top amount of exits for fund were in 2019. The important activity for fund was in 2019. The real fund results show that this VC is 14 percentage points more often commits exit comparing to other companies. This Invus works on 14 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from Invus is 500 millions - 1 billion dollars. The fund is constantly included in 2-6 deals per year.

Besides them, we counted 18 critical employees of this fund in our database.